BioCentury
ARTICLE | Company News

Capricor, Nile Therapeutics deal

July 15, 2013 7:00 AM UTC

Capricor will reverse-merge with Nile in a stock deal. Nile will issue Capricor stockholders shares of Nile stock so that Capricor will own about 90% of the combined company, which will be called Capricor Therapeutics Inc. Nile shareholders will own the remaining 10%. Capricor CEO Linda Marban will be CEO of the combined company, which will have representatives from both companies on its board. The deal, which has been approved by the boards of each company, is subject to Nile and Capricor stockholder approval. ...